First Documented Case of Iatrogenic Botulism in Poltava Region
A woman in the Poltava region has been hospitalized with botulism after receiving a cosmetic treatment involving botulinum toxin—marking the first recorded instance of iatrogenic botulism in the area. Her condition is currently classified as moderate, and treatment began with the administration of botulinum antitoxin. Iatrogenic botulism occurs when the toxin enters the bloodstream or spreads beyond the intended injection site, typically due to improper technique or unregulated products.
The incident took place at a private cosmetic clinic. This is the second botulism case reported in the region in 2026; the earlier one was linked to dried fish. According to the Poltava Regional Center for Disease Control and Prevention,
“Botulinum toxin is a registered pharmaceutical, but its use requires professional expertise. Systemic poisoning is considered a serious adverse reaction.”
Symptoms and Safety Recommendations
Common signs of botulism include:
- blurred or double vision,
- severe dry mouth,
- changes in voice,
- difficulty swallowing,
- muscle weakness,
- dizziness,
- extreme fatigue.
Health officials urge the public to exercise caution when selecting cosmetic services. They recommend choosing facilities that hold a medical license and verifying the certification of all products used. If any early symptoms appear, immediate medical attention is advised.
Last year, Ukraine recorded 26 suspected botulism cases, 15 of which occurred in April alone. Antitoxin supplies are available in every region of the country, ensuring timely treatment in case of poisoning.
This case highlights the critical need for vigilance when opting for cosmetic procedures, especially as botulinum toxin injections grow in popularity. Proper certification and licensing of clinics can significantly reduce the risks associated with such treatments. Patients must stay informed about potential complications and recognize the symptoms of botulism to respond quickly to health threats.